Williane Siqueira

Ms. Williane Siqueira

Department of Parasitology, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2020 in Biosensors
Verified
Journal Article
Open access
PDF file
BHBenjamin Heidt
Benjamin Heidt
Williane SiqueiraWilliane Siqueira
Williane Siqueira
KEKasper Eersels
Kasper Eersels
HDHanne Diliën
Hanne Diliën
BGBart Van Grinsven
Bart Van Grinsven
TCThomas Cleij
Thomas Cleij
Point of care (PoC) diagnostics are at the focus of government initiatives, NGOs and fundamental research alike. In high-income countries, the hope is to streamline the diagnostic procedure, minimize costs and make healthcare processes more efficient and faster, which, in some cases, can be more a matter of convenience than necessity. However, in resource-limited settings such as low-income countries, PoC-diagnostics might be the only viable route, when the next laboratory is hours away. Therefore, it is especially important to focus research into novel diagnostics for these countries in order to alleviate suffering due to infectious disease. In this review, the current research describing the use of PoC diagnostics in resource-limited settings and the potential bottlenecks along the value chain that prevent their widespread application is summarized. To this end, we will look at literature that investigates different parts of the value chain, such as fundamental research and market economics, as well as actual use at healthcare providers. We aim to create an integrated picture of potential PoC barriers, from the first start of research at universities to patient treatment in the field. Results from the literature will be discussed with the aim to bring all important steps and aspects together in order to illustrate how effectively PoC is being used in low-income countries. In addition, we discuss what is needed to improve the situation further, in order to use this technology to its fullest advantage and avoid “leaks in the pipeline”, when a promising device fails to take the next step of the valorization pathway and is abandoned.

31 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LDLucas Dhom-Lemos
Lucas Dhom-Lemos
AVAgostinho Gonçalves Viana
Agostinho Gonçalves Viana
JCJoão Luis Reis Cunha
João Luis Reis Cunha
MCMariana Santos Cardoso
Mariana Santos Cardoso
TMTiago Antônio Oliveira Mendes
Tiago Antônio Oliveira Mendes
RFRicardo Fujiwara
Ricardo Fujiwara
Visceral leishmaniasis (VL) or kala-azar, the most severe form of leishmaniasis, can lead to death if not properly diagnosed and treated. Correct identification of infected patients and reservoirs is vital for controlling the spread of leishmaniasis. Current diagnostic kits for leishmaniasis show high sensitivity and specificity, but can also result in false negatives and cross reactions with related parasitic infections. New diagnostic methods with greater accuracy are urgently needed for diagnosis of leishmaniasis. In this study, we aimed to uncover a new highly effective antigen for the diagnosis of visceral leishmaniasis in dogs and humans, aiming to improve the accuracy compared with those of current methods of diagnosis. Initially, in-silico epitope prediction analyses identified several potential B-cell epitopes in the repetitive region of Leishmania infantum kinesin, which co-localized with predicted structural disordered regions, suggesting high potential for antigenicity. Based on this analysis, 8.5 genomic motifs, which encode the repetitive sequence of 39 degenerate amino acids, were selected for recombinant expression. BLASTn analysis of this repetitive region indicated that it is absent in the T. cruzi parasite, which is closely related to Leishmania, indicating the specificity of this region. This potentially antigenic protein, named recombinant kinesin degenerated derived repeat (rKDDR), was recombinantly expressed in Escherichia coli BL21-Star using the pET28a-TEV expression vector. We then evaluated the performance of rKDDR in correctly diagnosing Leishmania infection and compared this new assay with currently used diagnostic tests for leishmaniasis. rKDDR showed greater sensitivity and specificity in correctly diagnosing leishmaniasis both in human (sensitivity 92.86% and specificity 100%) and canine (sensitivity 88.54% and specificity 97.30%) sera compared with those of rK39 (human: sensitivity 90.48% and specificity 97.92%; canine: sensitivity 78.13% and specificity 90.09%). In addition, the rKDDR-ELISA outperformed the EIE-LVC kit, which is the serologic kit recommended by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis. These results indicate that rKDDR is a highly promising candidate for diagnosis of visceral leishmaniasis, and is more accurate than the currently used gold-standard antigens.

1 May 2019 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
CAClaudia Abeijon
Claudia Abeijon
FAFabiana Alves
Fabiana Alves
SMSeverine Monnerat
Severine Monnerat
MWMonique Wasunna
Monique Wasunna
JMJane Mbui
Jane Mbui
ACAntonio Campos-Neto
Antonio Campos-Neto
Visceral leishmaniasis (VL) is a serious and fatal disease caused by the parasites Leishmania infantum and Leishmania donovani. The gold standard diagnostic test for VL is the demonstration of parasites or their DNA from spleen, lymph node or bone marrow aspirates. Serological tests exist but cannot distinguish active VL from either prior exposure to the parasites or subsequent to disease treatment. Using mass spectroscopy, we have previously identified three L. infantum protein biomarkers (Li-isd1, Li-txn1, and Li-ntf2) in urine of VL patients and developed a sensitive and specific urine-based antigen detection assay for diagnosis of VL that occurs in Brazil (where VL is caused by L. infantum). However, unpublished observations from our laboratory showed that these biomarkers were detected in only 55-60% of VL patients from India and Kenya, where the disease is caused by L. donovani. Here, we report the discovery and characterization of two new biomarkers of L. donovani (Ld-mao1 and Ld-ppi1) present in the urine of VL patients from these two countries. Capture ELISAs using specific rabbit IgG and chicken IgY were developed and the assays had sensitivities of 44.4% and 28.8% to detect Ld-mao1 and Ld-ppi1 respectively. In contrast, a multiplexed assay designed to simultaneously detect all five leishmanial biomarkers markedly increased the assay sensitivity to 82.2%. These results validate the utility of leishmanial protein biomarkers found in urine of VL patients as powerful tools for the development of an accurate diagnostic tests for this disease.

17 September 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Williane SiqueiraWilliane Siqueira
Williane Siqueira
AVAgostinho Gonçalves Viana
Agostinho Gonçalves Viana
JCJoão Luís Reis Cunha
João Luís Reis Cunha
LRLeticia Mansur Rosa
Leticia Mansur Rosa
LBLilian Lacerda Bueno
Lilian Lacerda Bueno
RFRicardo Fujiwara
Ricardo Fujiwara
Visceral leishmaniasis (VL) is caused by protozoa belonging to theLeishmania donovanicomplex and is considered the most serious and fatal form among the different types of leishmaniasis, if not early diagnosed and treated. Among the measures of disease control stand out the management of infected dogs and the early diagnosis and appropriate treatment of human cases. Several antigens have been characterized for use in the VL diagnosis, among them are the recombinant kinesin-derived antigens fromL.infantum, as rK39 and rKDDR. The main difference between these antigens is the size of the non-repetitive kinesin region and the number of repetitions of the 39 amino acid degenerate motif (6.5 and 8.5 repeats in rK39 and rKDDR, respectively). This repetitive region has a high antigenicity score. To evaluate the effect of increasing the number of repeats on diagnostic performance, we designed the rKDDR-plus antigen, containing 15.3 repeats of the 39 amino acid degenerate motif, besides the absence of the non-repetitive portion fromL.infantumkinesin. Its performance was evaluated by enzyme-linked immunosorbent assay (ELISA) and rapid immunochromatographic test (ICT), and compared with the kinesin-derived antigens (rKDDR and rK39). In ELISA with human sera, all recombinant antigens had a sensitivity of 98%, whereas the specificity for rKDDR-plus, rKDDR and rK39 was 100%, 96% and 71%, respectively. When evaluated canine sera, the ELISA sensitivity was 97% for all antigens, and the specificity for rKDDR-plus, rKDDR and rK39 was 98%, 91% and 83%, respectively. Evaluation of the ICT/rKDDR-plus, using human sera, showed greater diagnostic sensitivity (90%) and specificity (100%), when compared to the IT LEISH (79% and 98%, respectively), which is based on the rK39 antigen. These results suggest that the increased presence of repetitive motifs in the rKDDR-plus protein improves the diagnostic performance of serological tests by increasing the specificity and accuracy of the diagnosis.

1 December 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
TSThaís T.O. Santos
Thaís T.O. Santos
MCMariana S. Cardoso
Mariana S. Cardoso
AMAmanda S. Machado
Amanda S. Machado
Williane SiqueiraWilliane Siqueira
Williane Siqueira
FRFernanda F. Ramos
Fernanda F. Ramos
ECEDUARDO COELHO
EDUARDO COELHO

1 February 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
TSThaís T.O. Santos
Thaís T.O. Santos
AMAmanda S. Machado
Amanda S. Machado
FRFernanda F. Ramos
Fernanda F. Ramos
JOJoão A. Oliveira-Da-Silva
João A. Oliveira-Da-Silva
DLDaniela P. Lage
Daniela P. Lage
ECEDUARDO COELHO
EDUARDO COELHO